ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesChapter 11: Diseases of the digestive systemK73

K73

Non-billable

Chronic hepatitis, not elsewhere classified

Chapter 11:Diseases of the digestive system

BILLABLE STATUSNo
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/06/2025

Code Description

ICD-10 K73 is a used to indicate a diagnosis of chronic hepatitis, not elsewhere classified.

Key Diagnostic Point:

Chronic hepatitis, not elsewhere classified (K73) refers to a prolonged inflammation of the liver that persists for six months or longer. This condition can result from various etiologies, including viral infections (such as hepatitis B and C), autoimmune diseases, alcohol abuse, and metabolic disorders. Clinically, patients may present with fatigue, jaundice, abdominal discomfort, and elevated liver enzymes. The liver, a vital organ in the digestive system, plays a crucial role in metabolism, detoxification, and the production of bile. Chronic hepatitis can lead to progressive liver damage, fibrosis, cirrhosis, and even hepatocellular carcinoma if left untreated. Diagnostic considerations include serological tests for viral hepatitis markers, liver function tests, imaging studies (such as ultrasound), and liver biopsy to assess the degree of inflammation and fibrosis. It is essential to differentiate K73 from other forms of hepatitis, such as acute hepatitis (K71) and hepatitis due to specific infectious agents (K72).

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Diagnostic complexity: Requires thorough evaluation of liver function and potential underlying causes.
  • Treatment complexity: Management may involve antiviral therapy, lifestyle modifications, and monitoring for complications.
  • Documentation requirements: Detailed clinical documentation is necessary to support the diagnosis and treatment plan.
  • Coding specificity: While K73 is specific, it may require additional codes to capture the underlying cause or complications.

Audit Risk Factors

  • Common coding errors: Misclassification of chronic hepatitis as acute or failure to specify the underlying cause.
  • Documentation gaps: Incomplete records regarding the duration of symptoms or lack of follow-up notes.
  • Billing challenges: Potential denials due to insufficient documentation supporting the chronic nature of the condition.

Specialty Focus

Medical Specialties

Gastroenterology

Documentation Requirements

Standard ICD-10-CM documentation requirements apply

Common Clinical Scenarios

Various clinical presentations within this specialty area

Billing Considerations

Follow specialty-specific billing guidelines

Hepatology

Documentation Requirements

Standard ICD-10-CM documentation requirements apply

Common Clinical Scenarios

Various clinical presentations within this specialty area

Billing Considerations

Follow specialty-specific billing guidelines

Related CPT Codes

CPT Code

Clinical Scenario

Documentation Requirements

CPT Code

Clinical Scenario

Documentation Requirements

CPT Code

Clinical Scenario

Documentation Requirements

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

Chronic hepatitis significantly impacts population health, contributing to increased healthcare utilization due to complications such as cirrhosis and liver cancer. Quality measures often focus on the management of chronic liver disease, including regular monitoring of liver function and patient education on lifestyle modifications. Epidemiologically, chronic hepatitis is a major public health concern, particularly in populations with high rates of viral hepatitis, necessitating targeted screening and treatment programs.

ICD-9 vs ICD-10

Chronic hepatitis significantly impacts population health, contributing to increased healthcare utilization due to complications such as cirrhosis and liver cancer. Quality measures often focus on the management of chronic liver disease, including regular monitoring of liver function and patient education on lifestyle modifications. Epidemiologically, chronic hepatitis is a major public health concern, particularly in populations with high rates of viral hepatitis, necessitating targeted screening and treatment programs.

Reimbursement & Billing Impact

Reimbursement considerations include the need for clear evidence of ongoing management and monitoring of liver function. Common denials may arise from insufficient documentation or failure to demonstrate the chronicity of the condition. Best practices include maintaining comprehensive records of patient visits, laboratory results, and treatment plans to support claims effectively.

Resources

Clinical References

  • •
    ICD-10 Official Guidelines for K00-K99
  • •
    Clinical Documentation Requirements

Coding & Billing References

  • •
    ICD-10 Official Guidelines for K00-K99
  • •
    Clinical Documentation Requirements

Frequently Asked Questions

What specific conditions are covered by K73?

K73 encompasses chronic hepatitis due to various causes that do not fall under other specific categories, including chronic viral hepatitis, autoimmune hepatitis, and chronic hepatitis due to alcohol use. It is essential to document the specific etiology when applicable.

When should K73 be used instead of related codes?

K73 should be used when the hepatitis is chronic and not classified elsewhere, particularly when the underlying cause is unknown or when it does not fit into other specific categories like viral hepatitis or autoimmune hepatitis.

What documentation supports K73?

Documentation should include a detailed history of the patient's symptoms, laboratory results indicating liver function tests, imaging studies, and any relevant biopsy results. Follow-up notes demonstrating ongoing management and monitoring are also critical.